Intervacc and the Swedish University of Agricultural Sciences, SLU, extends a multi-year contract for the development of innovative animal health vaccines
Stockholm, December 19th, 2022 - Intervacc AB (publ) and the Swedish University of Agricultural Sciences, SLU, announce today that they have extended the contract for the development of animal health vaccines using recombinant proteins. The successful collaboration has led to a vaccine against equine strangles approved by the European Medicines Agency, as well as promising vaccine candidates against other streptococcal and staphylococcal infections. “Intervacc is very satisfied with the results that our research teams at SLU and KI have achieved together. We are convinced that more